Focal mycobacterial lymphadenitis following initiation of protease-inhibitor therapy in patients with advanced HIV-1 disease
- 1 January 1998
- journal article
- case report
- Published by Elsevier in The Lancet
- Vol. 351 (9098), 252-255
- https://doi.org/10.1016/s0140-6736(97)04352-3
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Treatment of Human Immunodeficiency Virus Infection with Saquinavir, Zidovudine, and ZalcitabineNew England Journal of Medicine, 1996
- A Preliminary Study of Ritonavir, an Inhibitor of HIV-1 Protease, to Treat HIV-1 InfectionNew England Journal of Medicine, 1995
- A Short-Term Study of the Safety, Pharmacokinetics, and Efficacy of Ritonavir, an Inhibitor of HIV-1 ProteaseNew England Journal of Medicine, 1995
- Structure-assisted Design of Nonpeptide Human Immunodeficiency Virus-1 Protease InhibitorsAmerican Journal of Respiratory and Critical Care Medicine, 1994
- Proteolytic processing of polyproteins in the replication of RNA virusesBiochemistry, 1989
- Genetic locus, primary structure, and chemical synthesis of human immunodeficiency virys proteaseGene Analysis Techniques, 1988
- Active human immunodeficiency virus protease is required for viral infectivity.Proceedings of the National Academy of Sciences, 1988
- Human immunodeficiency virus protease expressed in Escherichia coli exhibits autoprocessing and specific maturation of the gag precursor.Proceedings of the National Academy of Sciences, 1987
- A structural model for the retroviral proteasesNature, 1987
- Complete nucleotide sequence of the AIDS virus, HTLV-IIINature, 1985